Shopping Cart
Remove All
Your shopping cart is currently empty
Rafivirumab (CR57) is a monoclonal antibody targeting the rabies virus G protein, used in the study of rabies virus infection.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | - | In Stock | |
| 5 mg | $589 | - | In Stock | |
| 10 mg | $959 | - | In Stock | |
| 25 mg | $1,420 | - | In Stock | |
| 50 mg | $1,920 | - | In Stock |
| Description | Rafivirumab (CR57) is a monoclonal antibody targeting the rabies virus G protein, used in the study of rabies virus infection. |
| In vitro | Rafivirumab completely neutralizes the wild type ERA439 and N336D R346K with an EC50 of 3-5 pg/mL. [1] |
| In vivo | Rafivirumab improves survival in rats infected with rabies virus by intrathecal inoculation. [2] Rafivirumab (3-12 μg/kg, intramuscular injection) improved survival in Syrian hamsters infected with bat rabies virus [1]. |
| Synonyms | CR57, CR 57 |
| Cas No. | 944548-37-2 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.